Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Nystatin + triamcinolone acetonide 100000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin + triamcinolone acetonide 10000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin b sulfate + trimethoprim sulfate 10000unt/ns solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox 0.77% topical suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing benzalkonium and cetrimide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing chlorocresol and potassium hydroxyquinoline sulfate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorocresol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cetylpyridinium and lidocaine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Betamethasone- and neomycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Isopropyl alcohol- and triclosan-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ichthammol and zinc oxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol+flumethasone pivalate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing benzoyl peroxide and hydrocortisone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing nystatin and tolnaftate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ascorbic acid- and clioquinol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide- and sulfur-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tolnaftate+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide + clindamycin phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymyxin b sulfate + trimethoprim sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Colistin sulfate + hydrocortisone acetate + neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide- and potassium hydroxyquinoline sulfate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing metronidazole and nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing neomycin sulfate and polymyxin B sulfate and zinc bacitracin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin+chlorhexidine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ichthammol and zinc (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrocortisone acetate+neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Domiphen bromide+lidocaine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing benzalkonium chloride and tolnaftate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
médicament contenant dexaméthasone et néomycine et polymyxine B |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cetylpyridinium chloride+ ascorbic acid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzoyl peroxide- and erythromycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dexamethasone sodium phosphate and neomycin sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bacitracin zinc + polymyxin b sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin- and tetracycline-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol + hydrocortisone + pramoxine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100,000 units/ml oral suspension sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Neomycin 0.5% ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ecostatin 1% dry powder spray 200g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Local anti-infective and anti-inflammatory poisoning |
Causative agent (attribute) |
False |
Local anti-infective |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|